CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial Read more
‘Moonrise’ Initiative Signals Next Phase in Evolution for New-Look Moonbeam Network in Polkadot Ecosytem Read more
EverWind Fuels Announces Completion of FEED for its 1st Phase 240,000 Tonne per Annum Green Hydrogen-to-Green Ammonia Plant Read more
Skyharbour Partner Company Tisdale Clean Energy Mobilizes Crew and Equipment for Phase One Drill Program at the South Falcon East Uranium Project, Athabasca Basin, Saskatchewan Read more